CTNM Revenue

Annual Revenue

$50.00 M
NaN%

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

CTNM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.53%
CTNM annual revenue is higher than 47.53% of companies in Healthcare sector

High & Low

All-time High

$50.00 M
CTNM annual revenue is currently at an all-time high

3-Year Low

$50.00 M
CTNM annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CTNM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
CTNM next annual earnings announcement has not yet been scheduled

OtherCTNMprofitabilitymetrics:

Annual EPS

$1.12
CTNM annual earnings per share is $1.12

Annual Net Income

$22.72 M
CTNM annual net profit is $22.72 million

Annual Operating Profit

$16.08 M
CTNM annual operating income is $16.08 million

Annual Gross Profit

-
CTNM annual gross profit value is unknown

Quarterly Revenue

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTNM Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$50.00 M
CTNM quarterly revenue is currently at an all-time high

3-Year Low

$50.00 M
CTNM quarterly revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
CTNM next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

-
CTNM quarterly gross profit value is unknown

Quarterly Operating Profit

-$12.97 M
CTNM quarterly operating income is -$12.97 million

Quarterly Net Income

-$10.27 M
CTNM quarterly net profit is -$10.27 million

Quarterly EPS

-$0.40
CTNM quarterly earnings per share is -$0.40

TTM Revenue

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTNM TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$50.00 M
CTNM TTM revenue is currently at an all-time high

3-Year Low

$50.00 M
CTNM TTM revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
CTNM next earnings announcement has not yet been scheduled

OtherCTNMprofitabilitymetrics:

TTM Gross Profit

-
CTNM TTM gross profit value is unknown

TTM Operating Profit

-$43.52 M
CTNM TTM operating income is -$43.52 million

TTM Net Income

-$35.46 M
CTNM TTM net profit is -$35.46 million

TTM EPS

-$0.42
CTNM TTM earnings per share is -$0.42

CTNM Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CTNM Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat highat low
alltimeall timeat highat low

Contineum Therapeutics Class A Revenue History

DateAnnualQuarterlyTTM
Dec 2023
$50.00 M
-
-
DateAnnualQuarterlyTTM
Jun 2023
-
$50.00 M
$50.00 M

FAQ

  • What is Contineum Therapeutics Class A annual revenue?
  • What is the all time high annual revenue for Contineum Therapeutics Class A?
  • What is the all time high quarterly revenue for Contineum Therapeutics Class A?
  • What is the all time high TTM revenue for Contineum Therapeutics Class A?

What is Contineum Therapeutics Class A annual revenue?

The current annual revenue of CTNM is $50.00 M

What is the all time high annual revenue for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual revenue is $50.00 M

What is the all time high quarterly revenue for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly revenue is $50.00 M

What is the all time high TTM revenue for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM revenue is $50.00 M